Ad Hoc Announcements & Investor News
Clariant today announced its Fourth Quarter 2021 and audited Full Year 2021 results. Following the independent investigation, the 2020 Full Year and quarterly results have been restated and the quarters of 2021 have been corrected accordingly.
moreClariant today announced that it has scheduled its Annual General Meeting (AGM) for 24 June 2022, and that with the closing of the AGM the Governance Agreement between Clariant and SABIC will expire. Both parties entered into the agreement on 17 September 2018 when SABIC became Clariant’s anchor shareholder.
moreClariant today announced that it has concluded its previously announced investigation of accounting issues related to provisions and accruals. After reviewing the results of the investigation, the Board of Directors has determined the need for a restatement of the 2020 financial statements and corrections to the quarterly reporting of key financial data for 2020 and 2021.
moreClariant today announced that the publication of its Fourth Quarter / Full Year 2021 results will be delayed due to an investigation into accounting issues related to certain provisions and accruals. As a consequence, the publication of the Integrated Report 2021 and the Annual General Meeting of shareholders (AGM) will be postponed beyond the scheduled dates.
moreClariant today completed the sale of its Pigments business to a consortium of Heubach Group (“Heubach”) and SK Capital Partners (“SK Capital”). As announced upon signing of the transaction, the base enterprise value of the sale amounts to CHF 805 million subject to closing accounts adjustments and before a potential earn-out payment of CHF 50 million which is subject to the business’ 2021 financial performance.
moreClariant today announces that it has signed definitive agreements to acquire BASF’s U.S. Attapulgite business assets for USD 60 million in cash, including the signing of a long-term supply agreement for attapulgite-based products to BASF. The acquisition is subject to customary closing conditions and is expected to close in summer 2022.
moreClariant today will announce new 2025 financial targets at its Capital Markets Day associated with its new purpose-led strategy. Clariant expects to grow sales by 4-6 % annually, reach an EBITDA margin range of 19-21 % and generate a free cash flow conversion rate of around 40 % by 2025.
moreClariant today announced that the third quarter 2021 sales from continuing operations increased by a lofty 23 % in local currency and in Swiss francs to CHF 1.096 billion. Third quarter 2021 EBITDA margin increased to 16.4 % versus 14.2 % in the third quarter of 2020.
moreClariant today announced that the second quarter 2021 sales from continuing operations increased by 12 % in local currency to CHF 1.032 billion. This corresponds to an 11 % improvement in Swiss francs. Strong growth in Care Chemicals and Catalysis accompanied the particularly positive sales expansion reported in Natural Resources. This expansion was achieved via higher volumes and positive pricing in all Business Areas.
moreThe company has reached definitive agreements for the divestment of its Pigments business to a consortium of Heubach Group (“Heubach”) and SK Capital Partners (“SK Capital”) at an Enterprise Value (EV) of CHF 805 million to CHF 855 million on a cash and debt free basis, depending on an earn-out payment of CHF 50 million contingent on the 2021 financial performance of Clariant’s Pigments business.
moreClariant today announced its Fourth Quarter 2021 and audited Full Year 2021 results. Following the independent investigation, the 2020 Full Year and quarterly results have been restated and the quarters of 2021 have been corrected accordingly.
moreClariant today announced that it has scheduled its Annual General Meeting (AGM) for 24 June 2022, and that with the closing of the AGM the Governance Agreement between Clariant and SABIC will expire. Both parties entered into the agreement on 17 September 2018 when SABIC became Clariant’s anchor shareholder.
moreClariant today announced that it has concluded its previously announced investigation of accounting issues related to provisions and accruals. After reviewing the results of the investigation, the Board of Directors has determined the need for a restatement of the 2020 financial statements and corrections to the quarterly reporting of key financial data for 2020 and 2021.
moreClariant today announced that it has completed the divestment of its 50 % stake in the joint venture which owns Scientific Design Company Inc.
moreClariant today announced that it has joined the Renewable Carbon Initiative (RCI). The aim of the RCI is to support and accelerate the transition from the use of fossil carbon to the use of renewable carbon in the chemical industry. Switching to renewable carbon sources prevents additional fossil carbon entering the atmosphere and thus addresses a core problem of climate change.
moreClariant today announced it will suspend business with Russia in response to the Russian state’s intolerable acts of violence in the Ukraine with immediate effect.
moreClariant today announced that it is introducing a new global operating model for its Innovation & Sustainability unit. The reorganization aims to accelerate sustainability-driven innovation, which is a key component of Clariant’s purpose-led strategy ‘Greater chemistry – between people and planet’.
moreClariant today announced that the publication of its Fourth Quarter / Full Year 2021 results will be delayed due to an investigation into accounting issues related to certain provisions and accruals. As a consequence, the publication of the Integrated Report 2021 and the Annual General Meeting of shareholders (AGM) will be postponed beyond the scheduled dates.
moreClariant has signed definitive agreements to divest its 50 % stake in the joint venture which owns Scientific Design Company Inc. to its long-term joint venture partner, SABIC. SABIC is executing a call option raised in 2015 to acquire this stake, originally purchased by Süd-Chemie AG in 2003 and acquired by Clariant in 2011, pursuant to a change-of-control clause in the Joint Venture agreement.
moreClariant today completed the sale of its Pigments business to a consortium of Heubach Group (“Heubach”) and SK Capital Partners (“SK Capital”). As announced upon signing of the transaction, the base enterprise value of the sale amounts to CHF 805 million subject to closing accounts adjustments and before a potential earn-out payment of CHF 50 million which is subject to the business’ 2021 financial performance.
moreClariant today announces that it has signed definitive agreements to acquire BASF’s U.S. Attapulgite business assets for USD 60 million in cash, including the signing of a long-term supply agreement for attapulgite-based products to BASF. The acquisition is subject to customary closing conditions and is expected to close in summer 2022.
moreClariant today will announce new 2025 financial targets at its Capital Markets Day associated with its new purpose-led strategy. Clariant expects to grow sales by 4-6 % annually, reach an EBITDA margin range of 19-21 % and generate a free cash flow conversion rate of around 40 % by 2025.
moreClariant today announced that the third quarter 2021 sales from continuing operations increased by a lofty 23 % in local currency and in Swiss francs to CHF 1.096 billion. Third quarter 2021 EBITDA margin increased to 16.4 % versus 14.2 % in the third quarter of 2020.
moreClariant today announced the official completion of its sunliquid® cellulosic ethanol plant in Podari, Romania. The completed construction is an important next step for the commercial deployment of sunliquid® technology and thus supports Clariant’s sunliquid® licensing business strategy. The facility will be operational in the fourth quarter, producing cellulosic ethanol from agricultural residues.
moreClariant has signed an agreement to acquire the remaining 70% in Brazilian Personal Care Specialties company Beraca from the founding Sabará family. The acquisition is subject to regulatory approvals and is expected to close in Q4 2021.
moreClariant today announced that the second quarter 2021 sales from continuing operations increased by 12 % in local currency to CHF 1.032 billion. This corresponds to an 11 % improvement in Swiss francs. Strong growth in Care Chemicals and Catalysis accompanied the particularly positive sales expansion reported in Natural Resources. This expansion was achieved via higher volumes and positive pricing in all Business Areas.
moreClariant and India Glycols Limited (IGL) today announced the successful creation of their 51-49% joint venture for renewable ethylene oxide (EO) derivatives after receiving all necessary regulatory approvals. The joint venture will operate under the name Clariant IGL Specialty Chemicals Private Limited.
moreThe company has reached definitive agreements for the divestment of its Pigments business to a consortium of Heubach Group (“Heubach”) and SK Capital Partners (“SK Capital”) at an Enterprise Value (EV) of CHF 805 million to CHF 855 million on a cash and debt free basis, depending on an earn-out payment of CHF 50 million contingent on the 2021 financial performance of Clariant’s Pigments business.
moreClariant today announced first quarter 2021 continuing operations sales of CHF 1.002 billion, compared to CHF 1.019 billion in the first quarter of 2020. This corresponds to a 2 % increase in local currency, whereas depreciating currencies led to a 2 % decrease in Swiss francs. The local currency expansion was driven by positive pricing.
moreThe facility is jointly owned by Clariant and Beijing Tiangang Auxiliary Co., Ltd. (Tiangang), a privately owned producer and leading supplier of light stabilizers in China.
more